Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,714 public trials 622 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Recruiting

Seoul National University Airway Registry

NCT02527486

Conditions
Asthma, Asthma With Chronic Obstructive Pulmonary Disease, Bronchial Diseases, +16 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Seoul Metropolitan Government-Seoul National University Boramae Medical Center Seoul, South Korea
View Trial Details
Enrolling by Invitation

A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

NCT05735483

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 94 locations
View Trial Details
Enrolling by Invitation

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

NCT05396105

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +30 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Little Rock, Arkansas, United States
  • Study site San Diego, California, United States
  • Study site Santa Monica, California, United States
View all 60 locations
View Trial Details
Enrolling by Invitation

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

NCT05492578

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Allervie Clinical Research - Birmingham- Site Number : 8401101 Birmingham, Alabama, United States
  • Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Scottsdale Clinical Trials- Site Number : 8401149 Scottsdale, Arizona, United States
View all 390 locations
View Trial Details
Enrolling by Invitation

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT07256392

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Cahaba Dermatology & Skin Health Center, LLC Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Center for Dermatology & Plastic Surgery - Avacare Scottsdale, Arizona, United States
  • Kern Research Bakersfield, California, United States
View all 63 locations
View Trial Details
Enrolling by Invitation

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma

NCT06609239

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Chandler Clinical Research Trials- Site Number : 8400075 Chandler, Arizona, United States
  • Tucson Clinical Research Institute- Site Number : 8400085 Tucson, Arizona, United States
  • Allianz Research Institute - Aurora- Site Number : 8400026 Aurora, Colorado, United States
  • Western States Clinical Research- Site Number : 8400014 Wheat Ridge, Colorado, United States
View all 127 locations
View Trial Details

Related conditions